The application of rituximab during the conditioning regimen prevents Epstein - Barr virus infection following rATG-based haploidentical hematopoietic stem cell transplantation in the era of letermovir for cytomegalovirus prophylaxis - Poll - MDSpire

The application of rituximab during the conditioning regimen prevents Epstein - Barr virus infection following rATG-based haploidentical hematopoietic stem cell transplantation in the era of letermovir for cytomegalovirus prophylaxis

  • By

  • Jinxia Hao

  • Tongxin Zhang

  • Juan Ren

  • Xiaoning Wang

  • June 19, 2026

  • 0 min

Share

Original Source(s)

The application of rituximab during the conditioning regimen prevents Epstein - Barr virus infection following rATG-based haploidentical hematopoietic stem cell transplantation in the era of letermovir for cytomegalovirus prophylaxis

  • by Jinxia Hao, Tongxin Zhang, Juan Ren, Xiaoning Wang

  • June 19, 2026

Related Content

James Crawford Biggs 1931–2023

Paired dosimetric comparison of VMAT-based total body and total marrow irradiation in adult leukemia patients: enhanced organ sparing with consistent plan complexity

Visions for a JACIE Quality Management System 4.0